Curious to see your top suppliers emissions?
Book a demo for a pilot project
Formycon AG, a leading biopharmaceutical company headquartered in Germany, is renowned for its expertise in the development of biosimilars. Founded in 2002, the company has established a strong presence in Europe and beyond, focusing on innovative therapies that enhance patient care.
With a commitment to quality and efficacy, Formycon AG offers a range of biosimilar products that stand out for their rigorous development processes and regulatory compliance. The company has achieved significant milestones, including successful partnerships and product launches that underscore its position in the competitive biopharmaceutical landscape.
Recognised for its scientific excellence, Formycon AG continues to drive advancements in the industry, making substantial contributions to the accessibility of biologic treatments for patients worldwide.
55
DitchCarbon score
+15 vs industry average
Formycon AG’s score of 55 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Formycon AG?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Formycon AG's reported carbon emissions
In 2025, Formycon AG reported total carbon emissions of approximately 9.2 million kg CO2e. This figure includes Scope 1 emissions of about 8.4 million kg CO2e, Scope 2 emissions of approximately 6.9 million kg CO2e, and Scope 3 emissions of about 9,092 kg CO2e. The company has not set specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi).
In 2024, Formycon AG's total emissions were approximately 15.4 million kg CO2e, with Scope 1 emissions at about 8.7 million kg CO2e, Scope 2 emissions around 10.4 million kg CO2e, and Scope 3 emissions totalling approximately 15,232 kg CO2e.
Formycon AG's emissions data is not cascaded from any parent organization, indicating that the reported figures are solely from their own operations. The company continues to monitor its carbon footprint but currently lacks formal commitments to reduce emissions or participate in industry-wide climate initiatives.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Formycon AG’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Formycon AG yet.
Scope 3 top emissions categories
6 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Formycon AG7 months ago
55
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more